Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZBTB5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SMC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2K - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DHX15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTEN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSNK2A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CXADR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NT5DC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6866 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPT6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZMPSTE24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FARP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTC13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APH1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HGF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARMC8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DESI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on